BCR signaling is a central driver of CLL pathogenesis, regulating cellular proliferation, survival, and interactions with the microenvironment while exhibiting clinically significant interpatient heterogeneity. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.